Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03816202 · ClinicalTrials.gov registry record
Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 100
- Enrollment target
NCT03816202 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 100 participants.
The verdict
NCT03816202 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.
Interventions
- DEVICE Sundt carotid shunt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-04-25 |
| Est. Completion | 2019-08-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03816202
The ClinicalTrials.gov registry entry for NCT03816202 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sundt carotid shunt is the first listed.
NCT03816202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03816202 about?
NCT03816202 is a clinical study titled "Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)". The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.
What is the current status of trial NCT03816202?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-04-25. Estimated completion is 2019-08-27.
What interventions are being tested in trial NCT03816202?
The interventions under investigation include: Sundt carotid shunt (DEVICE).
Who is sponsoring clinical trial NCT03816202?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.